Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency'

 
• By Sue Sutter

Agency is going outside its ‘comfort zone’ to leverage different streams of existing real-world data sources to quickly assess the impact of potential treatment approaches, Amy Abernethy says; pandemic experience could lead to a more open embrace of RWE beyond the current public health emergency.

Many bubbles in water close up, abstract water wave with bubbles
US FDA is evaluating results that have bubbled up from different data streams organized into a series of critical categories. • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials